Page last updated: 2024-11-02

pentamidine and Breast Cancer

pentamidine has been researched along with Breast Cancer in 1 studies

Pentamidine: Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
pentamidine : A diether consisting of pentane-1,5-diol in which both hydroxyl hydrogens have been replaced by 4-amidinophenyl groups. A trypanocidal drug that is used for treatment of cutaneous leishmaniasis and Chagas disease.

Research Excerpts

ExcerptRelevanceReference
"Pentamidine is an aromatic diamine used for the treatment of human protozoa infections."1.37Pentamidine reduces expression of hypoxia-inducible factor-1α in DU145 and MDA-MB-231 cancer cells. ( Baek, WK; Jung, HJ; Park, JW; Suh, MH; Suh, SI, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jung, HJ1
Suh, SI1
Suh, MH1
Baek, WK1
Park, JW1

Other Studies

1 other study available for pentamidine and Breast Cancer

ArticleYear
Pentamidine reduces expression of hypoxia-inducible factor-1α in DU145 and MDA-MB-231 cancer cells.
    Cancer letters, 2011, Apr-01, Volume: 303, Issue:1

    Topics: Breast Neoplasms; Cell Line, Tumor; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male;

2011